Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$3.00+0.07 (+2.39%)
Close on Nov 11, 2026Market cap $126.37MP/E –Yield –
Apyx Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Apyx Medical's gross margin for the twelve months ending Sep 30, 2026 was 63.4%. For fiscal 2025 it was 62.5%, against 61.0% the year before. The highest annual figure on record is 69.3% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 62.5% | +1.5 |
| FY2024 | Dec 31, 2024 | 61.0% | −3.5 |
| FY2023 | Dec 31, 2023 | 64.5% | −1.0 |
| FY2022 | Dec 31, 2022 | 65.4% | −3.8 |
| FY2021 | Dec 31, 2021 | 69.3% | +6.1 |
| FY2020 | Dec 31, 2020 | 63.2% | −4.5 |
| FY2019 | Dec 31, 2019 | 67.6% | +2.4 |
| FY2018 | Dec 31, 2018 | 65.2% | −2.8 |
| FY2017 | Dec 31, 2017 | 68.0% | +10.0 |
| FY2016 | Dec 31, 2016 | 58.0% | +15.5 |
| FY2015 | Dec 31, 2015 | 42.5% | +10.1 |
| FY2014 | Dec 31, 2014 | 32.5% | −6.4 |
| FY2013 | Dec 31, 2013 | 38.9% | −2.1 |
| FY2012 | Dec 31, 2012 | 41.0% | −1.3 |
| FY2011 | Dec 31, 2011 | 42.2% | +1.0 |
| FY2010 | Dec 31, 2010 | 41.2% | −2.8 |
| FY2009 | Dec 31, 2009 | 44.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 64.2% | −0.3 |
| Q2 FY2026 | Jun 30, 2026 | 63.9% | +1.6 |
| Q1 FY2026 | Mar 31, 2026 | 63.5% | +3.4 |
| Q4 FY2025 | Dec 31, 2025 | 62.6% | −0.4 |
| Q3 FY2025 | Sep 30, 2025 | 64.4% | +3.9 |
| Q2 FY2025 | Jun 30, 2025 | 62.3% | +0.6 |
| Q1 FY2025 | Mar 31, 2025 | 60.1% | +2.0 |
| Q4 FY2024 | Dec 31, 2024 | 63.0% | +2.1 |
| Q3 FY2024 | Sep 30, 2024 | 60.5% | −6.1 |
| Q2 FY2024 | Jun 30, 2024 | 61.7% | −6.7 |
| Q1 FY2024 | Mar 31, 2024 | 58.1% | −4.3 |
| Q4 FY2023 | Dec 31, 2023 | 60.9% | −4.4 |
| Q3 FY2023 | Sep 30, 2023 | 66.6% | +3.5 |
| Q2 FY2023 | Jun 30, 2023 | 68.4% | +1.2 |
| Q1 FY2023 | Mar 31, 2023 | 62.4% | −3.4 |
| Q4 FY2022 | Dec 31, 2022 | 65.3% | −6.9 |
| Q3 FY2022 | Sep 30, 2022 | 63.2% | −4.9 |
| Q2 FY2022 | Jun 30, 2022 | 67.2% | +0.1 |
| Q1 FY2022 | Mar 31, 2022 | 65.8% | −2.1 |
| Q4 FY2021 | Dec 31, 2021 | 72.2% | +5.0 |
| Q3 FY2021 | Sep 30, 2021 | 68.1% | +0.1 |
| Q2 FY2021 | Jun 30, 2021 | 67.1% | +18.4 |
| Q1 FY2021 | Mar 31, 2021 | 67.8% | +8.1 |
| Q4 FY2020 | Dec 31, 2020 | 67.2% | +0.8 |
| Q3 FY2020 | Sep 30, 2020 | 67.9% | −1.9 |
| Q2 FY2020 | Jun 30, 2020 | 48.7% | −21.6 |
| Q1 FY2020 | Mar 31, 2020 | 59.7% | −3.6 |
| Q4 FY2019 | Dec 31, 2019 | 66.4% | +5.5 |
| Q3 FY2019 | Sep 30, 2019 | 69.9% | +1.2 |
| Q2 FY2019 | Jun 30, 2019 | 70.3% | +1.6 |
| Q1 FY2019 | Mar 31, 2019 | 63.3% | −1.8 |
| Q4 FY2018 | Dec 31, 2018 | 60.8% | −12.9 |
| Q3 FY2018 | Sep 30, 2018 | 68.7% | −3.5 |
| Q2 FY2018 | Jun 30, 2018 | 68.7% | +0.7 |
| Q1 FY2018 | Mar 31, 2018 | 65.1% | +17.0 |
| Q4 FY2017 | Dec 31, 2017 | 73.7% | +22.8 |
| Q3 FY2017 | Sep 30, 2017 | 72.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 68.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 48.1% | – |
| Q4 FY2016 | Dec 31, 2016 | 50.9% | – |
See a number that looks wrong?